LintonPharm Co.,Ltd.
Quick facts
Phase 3 pipeline
- The treatment of investigator choice · Oncology
The treatment of investigator choice works by targeting the underlying cause of the disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about LintonPharm Co.,Ltd.
What is LintonPharm Co.,Ltd.'s pipeline?
LintonPharm Co.,Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include The treatment of investigator choice.
Related
- Sector hub: All tracked pharma companies